Dr Bruce M Halpryn is a Cofounder, Chief Executive Officer and President at Eikonoklastes Therapeutics, Inc.. He possess expertise in technology transfer, pharmaceutical industry, biotechnology, commercialization, r&d and 30 more skills. Colleagues describe him as "I worked closely with Bruce in a variety of capacities for over a decade. Bruce's greatest strength is his able to straddle technical and commercial disciplines - integrating inputs from technical experts in order to enable top management to make the best business decisions. This was most apparent in Bruce's role as the Leader of our Due Diligence organization. Bruce assembled the best team, lead the Due Diligence process and integrated findings to form basis for robust… Show more" and "Bruce has been an invaluable resource to the hundreds of early stage life science companies that comprise each yearly cycle of a high-level commercialization initiative Larta Institute manages for the National Institutes of Health. Bruce is a hands-on expert who we tap to provide industry-level feedback,insight, and strategic direction to the most promising startups in the program. He is universally respected among the scientist/researcher-entrepreneurs that we guide in the program and… Show more"